{"id":135550,"date":"2021-09-20T18:00:00","date_gmt":"2021-09-20T18:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2915481"},"modified":"2021-09-20T18:00:00","modified_gmt":"2021-09-20T18:00:00","slug":"the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/","title":{"rendered":"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30)"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"5353 new20logo 01 2\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" title=\"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) 3\"><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" loading=\"lazy\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Beta-Thalassemia-Market-Insights.jpg?1632119775891\" alt=\"Beta-Thalassemia-Market-Insights\" width=\"695\" height=\"365\" title=\"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) 4\"><\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia market report<\/strong><\/a><span style=\"font-weight: 400;\"> thoroughly explains the Beta-Thalassemia historical and forecasted epidemiology, and Beta-Thalassemia market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan).<\/span><\/p>\n<p><strong>Some of the Key Highlights from the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Market Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to the National Organization for Rare Disorders, Beta-Thalassemia is a relatively rare autosomal recessive disorder in the United States, but it is one of the most common autosomal recessive disorders globally. The incidence of Beta-Thalassemia symptomatic cases in the general population is estimated to be <\/span><strong>1 in every 100,000<\/strong><span style=\"font-weight: 400;\"> people.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to Kattamis et al. (2018) study titled &#8220;Changing patterns in the epidemiology of beta-thalassemia,&#8221; approximately 1.5 percent of people worldwide are Beta-Thalassemia carriers.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Leading players such as <\/span><strong>Sangamo Therapeutics, Vifor Pharma, Imara, CRISPR Therapeutics, Vertex, <\/strong><span style=\"font-weight: 400;\">and others are working diligently towards the development of novel treatments for Beta-Thalassemia.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key pipeline therapies in the Beta-Thalassemia market include <\/span><strong>ST-400, VIT-2763, IMR-687, CTX001<\/strong><span style=\"font-weight: 400;\">, and several others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Vifor Pharma<\/strong><span style=\"font-weight: 400;\"> is developing <\/span><strong>VIT-2763<\/strong><span style=\"font-weight: 400;\">, using its expertise in iron metabolism to treat diseases such as beta-thalassemia. Both the FDA and the EMA designated vamifeport as an orphan drug for the treatment of Beta-Thalassemia.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>ST-400 <\/strong><span style=\"font-weight: 400;\">is an ex-vivo gene-edited cell therapy that uses <\/span><strong>Sangamo Therapeutics&#8217;<\/strong><span style=\"font-weight: 400;\"> zinc finger nuclease (ZFN) genome editing technology to modify a patient&#8217;s own hematopoietic stem cells (HSCs) into functional red blood cells using fetal hemoglobin.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Have queries? Request for sample @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Market Outlook<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>The Beta-Thalassemia market report<\/strong><\/a><span style=\"font-weight: 400;\"> covers current treatment practices, emerging drugs, Beta-Thalassemia market share of individual therapies, and current and forecasted Beta-Thalassemia market size from 208 to 2030, segmented by seven major markets.<\/span><\/p>\n<p><strong>Beta-Thalassemia: Overview<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Beta Thalassemia is a genetic disorder that is inherited autosomally and recessively. It is an inherited blood disorder characterized by low functional hemoglobin levels. Beta Thalassemia is a type of blood disorder. Beta-Thalassemia is classified into three types: Beta-Thalassemia minor, Beta-Thalassemia intermedia, and Beta-Thalassemia major. Symptoms of Beta-Thalassemia can range from mild to severe, depending on the type.<\/span><\/p>\n<p><strong>Beta-Thalassemia Epidemiology Segmentation<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The Beta-Thalassemia report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Beta-Thalassemia Prevalent Population<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Beta-Thalassemia Type-Specific Prevalent Population<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Beta-Thalassemia Diagnosed and Treatable Prevalent Cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Get the complete epidemiology analysis @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Epidemiology Insights<\/strong><\/a><\/p>\n<p><strong>Beta-Thalassemia Treatment Landscape<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Beta-Thalassemia has no specific treatment as it is a genetic disorder. The current treatment for Beta-Thalassemia focuses on delaying disease progression and relieving symptoms. Regular blood transfusions, medicines to remove excess iron from your body (called iron chelation therapy), surgery to remove the spleen, folic acid, surgery to remove the gallbladder, and bone marrow transplant are all possible treatments for Beta-Thalassemia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The FDA-approved drugs used for Beta-Thalassemia treatment are <\/span><strong>Betibeglogene autotemcel (beti-cel), Reblozyl (luspatercept-aamt), Luspatercept (ACE-536), <\/strong><span style=\"font-weight: 400;\">and others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Market<\/strong><\/a><strong>&nbsp;<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The Beta-Thalassemia market<\/span> <span style=\"font-weight: 400;\">is expected to witness the launch of upcoming therapies by key pharmaceutical companies including <\/span><strong>Sangamo Therapeutics, Vifor Pharma, Imara<\/strong><span style=\"font-weight: 400;\">, and several others. The launch of emerging therapies such as <\/span><strong>ST-400, VIT-2763, IMR-687, <\/strong><span style=\"font-weight: 400;\">and others<\/span><span style=\"font-weight: 400;\"> are anticipated to provide a major push to the growth of the Beta-Thalassemia market size in the forecast period 2021-30 in the 7MM.&nbsp;<\/span><\/p>\n<p><strong>Beta-Thalassemia&nbsp; Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">ST-400: <\/span><span style=\"font-weight: 400;\">Sangamo Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">VIT-2763: Vifor Pharma<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">IMR-687: Imara<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">CTX001: CRISPR Therapeutics \/Vertex<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">For more information on the pipeline therapies and companies, visit <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Drugs in Development<\/strong><\/a><\/p>\n<p><strong>Beta-Thalassemia Market Drivers<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Increase in research activities<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Advances in Genetics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Better Diagnostic Techniques<\/span><\/li>\n<\/ul>\n<p><strong>Beta-Thalassemia Market Barriers<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Global Transfusion Burden<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Continuity of Care<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Lack of Sustainable Development<\/span><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Scope of the Report<\/strong><\/a><\/p>\n<p><strong>Coverage: <\/strong><span style=\"font-weight: 400;\">7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)<\/span><\/p>\n<p><strong>Study Period: <\/strong><span style=\"font-weight: 400;\">2018-30<\/span><\/p>\n<p><strong>Beta-Thalassemia Key Companies: <\/strong><span style=\"font-weight: 400;\">Sangamo Therapeutics, Vifor Pharma, Imara, CRISPR Therapeutics, Vertex, among others.<\/span><strong>&nbsp;<\/strong><\/p>\n<p><strong>Beta-Thalassemia Key Pipeline Therapies:<\/strong><span style=\"font-weight: 400;\"> ST-400, VIT-2763, IMR-687, CTX001,<\/span> <span style=\"font-weight: 400;\">and others.<\/span><\/p>\n<p><strong>Beta-Thalassemia Segmentation: <\/strong><span style=\"font-weight: 400;\">By Geography, Beta-Thalassemia drugs<\/span><\/p>\n<p><strong>Analysis: <\/strong><span style=\"font-weight: 400;\">Comparative and conjoint analysis of <\/span><span style=\"font-weight: 400;\">&nbsp;Beta-Thalassemia<\/span><span style=\"font-weight: 400;\"> emerging therapies<\/span><\/p>\n<p><strong>Tools Used: <\/strong><span style=\"font-weight: 400;\">SWOT Analysis<\/span><\/p>\n<p><strong>Case Studies<\/strong><\/p>\n<p><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p><strong>Analyst&rsquo;s Views<\/strong><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">1.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Report Introduction<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">2.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia: Market Overview at a Glance<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">3.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Disease Background and Overview: Beta Thalassemia<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">4.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Epidemiology and Patient Population (7MM)<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">5.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia: Country-wise Epidemiology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">6.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Treatments and Medical Practices<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">7.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Current Treatment<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">8.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Emerging Therapies<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">9.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">7MM Beta Thalassemia Market Analysis<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">10.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia 7MM: Country-wise Market Analysis<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">11.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia United States Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">12.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia EU5 Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">13.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Japan Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">14.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Market Drivers<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">15.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Beta Thalassemia Market Barriers<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">16.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Report Methodology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">17.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">18.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">Disclaimer<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 10.3922%; height: 17px;\">19.<\/td>\n<td style=\"width: 89.6078%; height: 17px;\"><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Know more about report offerings @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/beta-thalassemia-thal-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Beta-Thalassemia Market<\/strong><\/a><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/thalassemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Thalassemia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Thalassemia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Thalassemia, historical and forecasted epidemiology as well as the Thalassemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemophilia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Hemophilia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Hemophilia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; <\/strong><span style=\"font-weight: 400;\">report delivers an in-depth understanding of the Hemophilia, historical and forecasted epidemiology as well as the Hemophilia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemophilia-a2030-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Hemophilia A<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Hemophilia A<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Novo Nordisk, <\/strong><strong>Shire, Sanofi, Bayer, Roche, Pfizer,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemophilia-b-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Hemophilia B<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Hemophilia B<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Spark Therapeutics, UniQure Biopharma B.V., ApcinteX Ltd, Freeline Therapeutics,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/high-grade-glioma-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>High Grade Glioma Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">High Grade Glioma<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Merck, Orbus Therapeutics,&nbsp; Bayer, MedImmune, DNAtrix,<\/strong><span style=\"font-weight: 400;\"> among others.&nbsp;<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myocarditis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Myocarditis<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Myocarditis<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as<\/span> <strong>Cardiol Therapeutics, <\/strong><span style=\"font-weight: 400;\">among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/multiple-myeloma-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Multiple Myeloma<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Multiple Myeloma<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Johnson &amp; Johnson, Amgen,&nbsp; BioLineRx, Bristol-Myers Squibb, ExCellThera, Pfizer,&nbsp; Takeda, Precision BioSciences,&nbsp; Poseida Therapeutics,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/fibromyalgia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Fibromyalgia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Fibromyalgia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/palmar-fibromatosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Palmar Fibromatosis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Palmar Fibromatosis Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Palmar Fibromatosis, historical and forecasted epidemiology as well as the Palmar Fibromatosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemostasis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Hemostasis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Hemostasis Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Hemostasis, historical and forecasted epidemiology as well as the Hemostasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/consulting\/market-assessment-services?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">About<\/span><a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"> <strong>DelveInsight<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform<\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"> <strong>PharmDelve<\/strong><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n<p><strong>Contact Us&nbsp;<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Sandeep Joshi&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">info@delveinsight.com&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">+1(919)321-6187&nbsp;<\/span><\/p>\n<p><a href=\"http:\/\/www.delveinsight.com\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">www.delveinsight.com<\/span><\/a><\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\" target=\"_blank\" rel=\"noopener\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\" target=\"_blank\" rel=\"noopener\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\" target=\"_blank\" rel=\"noopener\"> <strong>Twitter<\/strong><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-market-sales-forecast\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Market Sales Forecast<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-symptoms\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Symptoms<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-treatment\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Treatment<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-therapies\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Therapies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-companies\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Companies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-market\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/beta-thalassemia-market-size\/\" rel=\"tag noopener\" target=\"_blank\">Beta Thalassemia Market Size<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Sandeep Joshi\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag noopener\" target=\"_blank\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag noopener\" target=\"_blank\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/pr-wirein\/\" rel=\"category tag noopener\" target=\"_blank\">PR-Wirein<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag noopener\" target=\"_blank\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag noopener\" target=\"_blank\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag noopener\" target=\"_blank\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag noopener\" target=\"_blank\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag noopener\" target=\"_blank\">English<\/a><\/p>\n<\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Sandeep Joshi\u00a0<\/p>\n<p> info@delveinsight.com\u00a0<\/p>\n<p> +1(919)321-6187<\/p>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s Beta-Thalassemia market report thoroughly explains the Beta-Thalassemia historical and forecasted epidemiology, and Beta-Thalassemia market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan). Some of the Key Highlights from the Beta-Thalassemia Market Report According to the National Organization for Rare Disorders, Beta-Thalassemia is a relatively rare [&hellip;] <a href=\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-135550","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s Beta-Thalassemia market report thoroughly explains the Beta-Thalassemia historical and forecasted epidemiology, and Beta-Thalassemia market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan). Some of the Key Highlights from the Beta-Thalassemia Market Report According to the National Organization for Rare Disorders, Beta-Thalassemia is a relatively rare [&hellip;] Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-20T18:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\",\"name\":\"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png\",\"datePublished\":\"2021-09-20T18:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/","og_locale":"en_US","og_type":"article","og_title":"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business","og_description":"DelveInsight&rsquo;s Beta-Thalassemia market report thoroughly explains the Beta-Thalassemia historical and forecasted epidemiology, and Beta-Thalassemia market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan). Some of the Key Highlights from the Beta-Thalassemia Market Report According to the National Organization for Rare Disorders, Beta-Thalassemia is a relatively rare [&hellip;] Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/","og_site_name":"Business","article_published_time":"2021-09-20T18:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/","url":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/","name":"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30) - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png","datePublished":"2021-09-20T18:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/09\/5353-new20logo-01-2.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/20\/the-beta-thalassemia-treatment-market-is-expected-to-grow-significantly-due-to-the-launch-of-emerging-therapies-during-the-forecast-period-2021-30\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"The Beta-Thalassemia treatment market is expected to grow significantly due to the launch of emerging therapies during the forecast period (2021-30)"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/135550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=135550"}],"version-history":[{"count":9,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/135550\/revisions"}],"predecessor-version":[{"id":135927,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/135550\/revisions\/135927"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=135550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=135550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=135550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}